ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
4.360
+0.065 (1.51%)
At close: Oct 7, 2026, 4:00 PM EDT
4.370
+0.010 (0.23%)
Pre-market: Oct 8, 2026, 4:01 AM EDT
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $433.59 million as of October 7, 2026. That makes ARS Pharmaceuticals the 15,885th most valuable company in the world and 2,873rd in the United States. Its market cap has decreased by 57.28% in one year.
Market Cap
433.59M
Enterprise Value
461.35M
1-Year Change
-57.28%
Global Rank
Country Rank
#2,873 United States
Category
ChartMarket Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has decreased from $568.25M to $433.59M, a decrease of -23.70%. That is a compound annual growth rate of -6.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 433.59M | -62.35% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Assembly Biosciences | 451.60M |
| Capricor Therapeutics | 450.58M |
| DiaMedica Therapeutics | 438.42M |
| Tectonic Therapeutic | 438.10M |
| Entera Bio | 438.05M |
| YD Bio | 435.61M |
| AgomAb Therapeutics NV | 435.35M |
| Editas Medicine | 419.27M |